The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

Harmony Healthcare IT, an innovator of health data management and platform solutions, today announced a preferred technology partnership with OCHIN, a national non-profit health IT organization that ...

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...

There are synthetic components to build in the RNA in a stable way, but the main components of the aNP platform are the body's own fats and proteins." In this way, far fewer side effects are to be ...